A carregar...

Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain

BACKGROUND: The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including best supportive care, low dose chemotherapy and standard dose chemotherapy. ME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Crespo, Carlos, Moreno, Estela, Sierra, Jordi, Serip, Suzan, Rubio, Marta
Formato: Artigo
Idioma:Inglês
Publicado em: Springer 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029489/
https://ncbi.nlm.nih.gov/pubmed/24314138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-1991-3-28
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!